Cargando…

Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics

PURPOSE: To test radiomics for prognostication of intrahepatic mass-forming cholangiocarcinoma (IMCC) and to develop a comprehensive risk model. METHODS: Histologically proven IMCC (representing the full range of stages) were retrospectively analyzed by volume segmentation on baseline hepatic venous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Mario, Maddalo, Michele, Leoni, Eleonora, Giuliotti, Sara, Milanese, Gianluca, Ghetti, Caterina, Biasini, Elisabetta, De Filippo, Massimo, Missale, Gabriele, Sverzellati, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435517/ https://www.ncbi.nlm.nih.gov/pubmed/34165602 http://dx.doi.org/10.1007/s00261-021-03183-9

Ejemplares similares

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
por: Saha, Supriya K., et al.
Publicado: (2016)

An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
por: Madoff, David C, et al.
Publicado: (2022)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size
por: Kolck, Johannes, et al.
Publicado: (2023)

Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma
por: Chen, Xiang, et al.
Publicado: (2022)

Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study
por: Sutton, Thomas L., et al.
Publicado: (2021)

Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
por: Barner‐Rasmussen, Nina, et al.
Publicado: (2021)

Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Holster, Jessica J., et al.
Publicado: (2022)

Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
por: Franssen, Stijn, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review
por: Norero, Blanca, et al.
Publicado: (2023)

ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study
por: Li, Jun, et al.
Publicado: (2020)

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017
por: Javle, Milind, et al.
Publicado: (2022)

DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
por: Zheng, Jing, et al.
Publicado: (2023)

Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
por: Schneider, Hannah, et al.
Publicado: (2023)

Extreme In Situ Liver Surgery Under Total Vascular Exclusion with Right Hepatic Vein and Inferior Vena Cava Grafts for an Intrahepatic Cholangiocarcinoma
por: Lopez-Lopez, Victor, et al.
Publicado: (2022)

Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta‐analysis
por: Weichselbaum, Laura, et al.
Publicado: (2022)

A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features
por: Shen, Keren, et al.
Publicado: (2023)

Association of Laparoscopic Surgery with Improved Perioperative and Survival Outcomes in Patients with Resectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis from Propensity-Score Matched Studies
por: Aliseda, Daniel, et al.
Publicado: (2023)

Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma
por: He, Guangming, et al.
Publicado: (2023)

Detection of fatty liver using virtual non-contrast dual-energy CT
por: Zhang, Pengcheng Peter, et al.
Publicado: (2022)

Clinical application of the contrast-enhancement boost technique in computed tomography angiography of the portal vein
por: Hou, Juan, et al.
Publicado: (2022)

Contrast-enhanced ultrasound for screening hepatocellular carcinoma: an implemented program at a semi-rural academic center
por: Motz, Victoria L., et al.
Publicado: (2021)

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis
por: Ishibashi, Hiroyuki, et al.
Publicado: (2011)

Inflammatory myofibroblastic tumour of liver masquerading as hilar cholangiocarcinoma
por: Subash, R, et al.
Publicado: (2011)

Apparent diffusion coefficient correlates with different histopathological features in several intrahepatic tumors
por: Surov, Alexey, et al.
Publicado: (2023)

Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2012)

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0
por: Zanetto, Alberto, et al.
Publicado: (2023)

A rare case of non-metastatic cholangiocarcinoma in a long standing choledochal cyst
por: Goukassian, ID, et al.
Publicado: (2012)

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2015)

Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma
por: Mantel, Hendrik T. J., et al.
Publicado: (2015)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma
por: van Keulen, Anne-Marleen, et al.
Publicado: (2023)

Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy
por: Coelen, Robert J. S., et al.
Publicado: (2016)

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
por: Olthof, Pim B., et al.
Publicado: (2020)

Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy
por: Sucher, Robert, et al.
Publicado: (2020)

Multi-organ Radiomics-Based Prediction of Future Remnant Liver Hypertrophy Following Portal Vein Embolization
por: Gerwing, Mirjam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kfh3ikolvsdojsqgko7f4v6oto